Boris K Kurbatov

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Acute Myocardial Infarction

Tyrosine Kinase

Reactive Oxygen Species

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Sergey V Popov, Alexander V Mukhomedzyanov, Leonid N Maslov, Natalia V Naryzhnaya, Boris K Kurbatov, N Rajendra Prasad, Nirmal Singh, Feng Fu, Viatcheslav N Azev
The Infarct-Reducing Effect of the δ 2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism. Membranes 13 (1) (2023)
Sergey V Popov, Alexander V Mukhomedzyanov, Leonid N Maslov, Natalia V Naryzhnaya, Boris K Kurbatov, N Rajendra Prasad, Nirmal Singh, Feng Fu, Viatcheslav N Azev
The Infarct-Reducing Effect of the δ 2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism. Membranes 13 (1) (2023)
Sergey V Popov, Leonid N Maslov, Alexander V Mukhomedzyanov, Boris K Kurbatov, Alexandr S Gorbunov, Michail Kilin, Viatcheslav N Azev, Maria S Khlestkina, Galina Z Sufianova
Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling. Pharmaceutics 15 (3) (2023)
Natalia V Naryzhnaya, Alexander V Mukhomedzyanov, Maria Sirotina, Leonid N Maslov, Boris K Kurbatov, Alexander S Gorbunov, Mikhail Kilin, Artur Kan, Andrey V Krylatov, Yuri K Podoksenov, Sergey V Logvinov
δ-Opioid Receptor as a Molecular Target for Increasing Cardiac Resistance to Reperfusion in Drug Development. Biomedicines 11 (7) (2023)
Sergey V Popov, Alexander V Mukhomedzyanov, Leonid N Maslov, Natalia V Naryzhnaya, Boris K Kurbatov, N Rajendra Prasad, Nirmal Singh, Feng Fu, Viatcheslav N Azev
The Infarct-Reducing Effect of the δ 2 Opioid Receptor Agonist Deltorphin II: The Molecular Mechanism. Membranes 13 (1) (2023)
Sergey V Popov, Leonid N Maslov, Alexander V Mukhomedzyanov, Boris K Kurbatov, Alexandr S Gorbunov, Michail Kilin, Viatcheslav N Azev, Maria S Khlestkina, Galina Z Sufianova
Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling. Pharmaceutics 15 (3) (2023)
Sergey V Popov, Leonid N Maslov, Alexander V Mukhomedzyanov, Boris K Kurbatov, Alexandr S Gorbunov, Michail Kilin, Viatcheslav N Azev, Maria S Khlestkina, Galina Z Sufianova
Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling. Pharmaceutics 15 (3) (2023)
Natalia V Naryzhnaya, Olga A Koshelskaya, Irina V Kologrivova, Tatiana E Suslova, Olga A Kharitonova, Sergey L Andreev, Alexander S Gorbunov, Boris K Kurbatov, Alla A Boshchenko
Production of Reactive Oxygen Species by Epicardial Adipocytes Is Associated with an Increase in Postprandial Glycemia, Postprandial Insulin, and a Decrease in Serum Adiponectin in Patients with Severe Coronary Atherosclerosis. Biomedicines 10 (8) (2022)